The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients.

A drug used to treat high blood pressure may reduce the risk of kidney failure in obese patients.

HOBOKEN, N.J., March 2, 2011 /PRNewswire/ -- The American Heart Association estimates 35 percent of adults in the U.S.

RIDGEFIELD, Conn., June 13 /PRNewswire/ -- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients.

DEERFIELD, Ill.